AYTU
Aytu BioPharma·NASDAQ
--
--(--)
--
--(--)
10.79 / 10
Outperform
Sentiment is very positive (10.79) with a 100% Strong‑Buy rating from one analyst (Edward Woo, Ascendiant Capital) and a weighted historical rating of 13.86. Fund‑flow score is 7.73 (good), overall inflow ratios are positive except small‑cap flow, reinforcing bullish outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-10
InstitutionAscendiant Capital
Times predicted3
Historical Win Rate100.0%
What is the market sentiment for AYTU?
- AYTU holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 10.79/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
